Literature DB >> 22034092

Determinants of the specificity of protease-activated receptors 1 and 2 signaling by factor Xa and thrombin.

Soumendra Rana1, Likui Yang, Seyed Mahdi Hassanian, Alireza R Rezaie.   

Abstract

Factor Xa (FXa) elicits intracellular signaling responses through the activation of protease-activated receptor 2 (PAR2) and possibly also through PAR1 in endothelial cells. In this study, we investigated FXa signaling in endothelial cells when the protease was either in free form or assembled into the prothrombinase complex. Furthermore, we prepared several wild-type and mutant PAR1 and PAR2 cleavage-reporter constructs in which their exodomains were fused to cDNA encoding for a soluble alkaline phosphatase (ALP). In the mutants, P2 residues were exchanged between PAR1 and PAR2 cleavage-reporter constructs and the hirudin-like binding site (HLBS) of PAR1 was inserted into the homologous site of PAR2. In non-transfected cells, FXa elicited a protective response which could be blocked by a specific anti-PAR2 but not by an anti-PAR1 antibody. A similar protective activity was observed for FXa in the prothrombinase complex. Further studies revealed that neither the Gla- nor EGF1-domain of FXa is required for its signaling activity, however, the N-terminus Arg-86 and Lys-87 of the EGF2-domain were essential. In the cleavage-reporter transfected cells, FXa cleaved the PAR2 construct effectively, however, replacing its P2-Gly with P2-Pro of PAR1 impaired its cleavage by FXa but improved it by thrombin. A PAR2 construct containing both P2-Pro and HLBS of PAR1 was poorly cleaved by FXa, but effectively by thrombin. A PAR1 construct containing P2 and P3 residues of PAR2 was poorly cleaved by thrombin but effectively by FXa. These results provide new insight into mechanisms through which coagulation proteases specifically interact with their target PAR receptors.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22034092      PMCID: PMC3264766          DOI: 10.1002/jcb.23427

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  35 in total

1.  Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa.

Authors:  Lin Chen; Chandrashekhara Manithody; Likui Yang; Alireza R Rezaie
Journal:  Protein Sci       Date:  2004-02       Impact factor: 6.725

2.  The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity.

Authors:  L W Liu; T K Vu; C T Esmon; S R Coughlin
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.157

Review 3.  Cofactor proteins in the assembly and expression of blood clotting enzyme complexes.

Authors:  K G Mann; R J Jenny; S Krishnaswamy
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

4.  Isolation and characterization of a cDNA encoding a human liver/bone/kidney-type alkaline phosphatase.

Authors:  M J Weiss; P S Henthorn; M A Lafferty; C Slaughter; M Raducha; H Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

Review 5.  Blood coagulation.

Authors:  C M Jackson; Y Nemerson
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

6.  Mapping of the catalytic groove preferences of factor Xa reveals an inadequate selectivity for its macromolecule substrates.

Authors:  Elsa P Bianchini; Virginie B Louvain; Pierre-Emmanuel Marque; Maria A Juliano; Luiz Juliano; Bernard F Le Bonniec
Journal:  J Biol Chem       Date:  2002-03-29       Impact factor: 5.157

7.  Role of basic residues of the autolysis loop in the catalytic function of factor Xa.

Authors:  Chandrashekhara Manithody; Likui Yang; Alireza R Rezaie
Journal:  Biochemistry       Date:  2002-05-28       Impact factor: 3.162

8.  Mutagenesis studies toward understanding the mechanism of differential reactivity of factor Xa with the native and heparin-activated antithrombin.

Authors:  Alireza R Rezaie; Likui Yang; Chandrashekhara Manithody
Journal:  Biochemistry       Date:  2004-03-16       Impact factor: 3.162

Review 9.  Specificity of coagulation factor signaling.

Authors:  W Ruf; A Dorfleutner; M Riewald
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

10.  The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment.

Authors:  W Bode; I Mayr; U Baumann; R Huber; S R Stone; J Hofsteenge
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

View more
  13 in total

1.  Identification of exosite residues of factor Xa involved in recognition of PAR-2 on endothelial cells.

Authors:  Chandrashekhara Manithody; Likui Yang; Alireza R Rezaie
Journal:  Biochemistry       Date:  2012-03-15       Impact factor: 3.162

Review 2.  Protease-activated receptor signalling by coagulation proteases in endothelial cells.

Authors:  Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2014-07-03       Impact factor: 5.249

Review 3.  The emerging role of coagulation proteases in kidney disease.

Authors:  Thati Madhusudhan; Bryce A Kerlin; Berend Isermann
Journal:  Nat Rev Nephrol       Date:  2015-11-23       Impact factor: 28.314

4.  Activated factor X signaling via protease-activated receptor 2 suppresses pro-inflammatory cytokine production from lipopolysaccharide-stimulated myeloid cells.

Authors:  Eimear M Gleeson; James S O'Donnell; Emily Hams; Fionnuala Ní Áinle; Bridget-Ann Kenny; Padraic G Fallon; Roger J S Preston
Journal:  Haematologica       Date:  2013-07-19       Impact factor: 9.941

5.  Parenteral administration of factor Xa/IIa inhibitors limits experimental aortic aneurysm and atherosclerosis.

Authors:  Corey S Moran; Sai-Wang Seto; Smriti M Krishna; Surabhi Sharma; Roby J Jose; Erik Biros; Yutang Wang; Susan K Morton; Jonathan Golledge
Journal:  Sci Rep       Date:  2017-02-21       Impact factor: 4.379

Review 6.  Antiviral anticoagulation.

Authors:  Edward L G Pryzdial; Michael R Sutherland; Bryan H Lin; Marc Horwitz
Journal:  Res Pract Thromb Haemost       Date:  2020-07-06

7.  Rivaroxaban modulates electrical and mechanical characteristics of left atrium.

Authors:  Chien-Jung Chang; Yao-Chang Chen; Yung-Kuo Lin; Jen-Hung Huang; Shih-Ann Chen; Yi-Jen Chen
Journal:  J Biomed Sci       Date:  2013-03-15       Impact factor: 8.410

8.  Apixaban Enhances Vasodilatation Mediated by Protease-Activated Receptor 2 in Isolated Rat Arteries.

Authors:  Ambra Villari; Giovanni Giurdanella; Claudio Bucolo; Filippo Drago; Salvatore Salomone
Journal:  Front Pharmacol       Date:  2017-07-18       Impact factor: 5.810

9.  Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome.

Authors:  Bahar Artim-Esen; Natalia Smoktunowicz; Thomas McDonnell; Vera M Ripoll; Charis Pericleous; Ian Mackie; Eifion Robinson; David Isenberg; Anisur Rahman; Yiannis Ioannou; Rachel C Chambers; Ian Giles
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

10.  Tissue Factor-Expressing Tumor-Derived Extracellular Vesicles Activate Quiescent Endothelial Cells via Protease-Activated Receptor-1.

Authors:  Sara P Y Che; Jeannie Y Park; Tracy Stokol
Journal:  Front Oncol       Date:  2017-11-02       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.